Royal Bank Of Canada Avita Medical, Inc. Transaction History
Royal Bank Of Canada
- $425 Billion
- Q2 2024
A detailed history of Royal Bank Of Canada transactions in Avita Medical, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 2,566 shares of RCEL stock, worth $27,558. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,566
Previous 1,542
66.41%
Holding current value
$27,558
Previous $24,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RCEL
# of Institutions
72Shares Held
6.03MCall Options Held
11.6KPut Options Held
40.1K-
Black Rock Inc. New York, NY1.78MShares$19.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA586KShares$6.29 Million0.0% of portfolio
-
State Street Corp Boston, MA508KShares$5.46 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT267KShares$2.87 Million0.21% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $269M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...